Actimab-M: Ph I started

Actinium began an open-label, U.S. Phase I trial to evaluate IV Actimab-M on day 1 of each 42-day cycle in about 12 patients. The starting dose of Actimab-M is 0.5 µCi/kg, which may be increased to 1 ...